Dupilumab Treatment Provides Multidimensional Benefits in Patients with Prurigo Nodularis.

Saved in:
Bibliographic Details
Title: Dupilumab Treatment Provides Multidimensional Benefits in Patients with Prurigo Nodularis.
Authors: Ständer S; Section Pruritus Medicine, Department of Dermatology and Center for Chronic Pruritus, University Hospital Münster, Münster, Germany. sonja.staender@ukmuenster.de., Yosipovitch G; Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery and Miami Itch Center, University of Miami, Miami, FL, USA., Kwatra SG; Department of Dermatology, University of Maryland School of Medicine, Baltimore, MD, USA.; Maryland Itch Center, University of Maryland Medical Center, Baltimore, MD, USA., Mendes-Bastos P; Dermatology Center, Hospital CUF Descobertas, Lisbon, Portugal., Tsai TF; Department of Dermatology, National Taiwan University Hospital, Taipei City, Taiwan., Nakajima S; Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan., Praestgaard AH; Sanofi, Cambridge, MA, USA., Zahn J; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Wiggins S; Sanofi, Reading, UK.
Source: Dermatology and therapy [Dermatol Ther (Heidelb)] 2026 Jun; Vol. 16 (6), pp. 3189-3200. Date of Electronic Publication: 2026 May 13.
Publication Type: Journal Article
Journal Info: Publisher: Springer Healthcare Communications Country of Publication: Switzerland NLM ID: 101590450 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8210 (Print) NLM ISO Abbreviation: Dermatol Ther (Heidelb) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2193-8210
DOI:10.1007/s13555-026-01777-z